Results 81 to 90 of about 12,566 (192)

Orlistat in the prevention of diabetes in the obese patient

, 2008
Marcio C Mancini, Alfredo HalpernObesity and Metabolic Syndrome Group, Endocrinology and Metabolism Department, Faculty of Medicine, University of São Paulo, São Paulo, SP, BrazilAbstract: There has been an increase in the concern about ...
Marcio C Mancini, Alfredo Halpern
core  

Evaluation of efficacy and safety of orlistat in obese patients

Indian Journal of Endocrinology and Metabolism, 2011
Context: Rapidly rising prevalence of obesity is alarming. Obesity predisposes to co-morbidities like hypertension, type 2 diabetes mellitus, dyslipidemias, thus substantially rising healthcare expenditure. Lifestyle modifications alone have very limited
Suyog S Jain, Sunita J Ramanand, Jaiprakash B Ramanand, Pramod B Akat, Milind H Patwardhan, Sachin R Joshi   +5 more
doaj   +1 more source

Clinical and economic considerations of antiobesity treatment: a review of orlistat

ClinicoEconomics and Outcomes Research, 2010
Armineh ZohrabianDivision of Adult and Community Health, Centers for Disease Control and Prevention, Atlanta, GA, USAAbstract: The objective of this study was to review the current knowledge about the use of orlistat from clinical and economic ...
Armineh Zohrabian
doaj  

Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial

Lipids in Health and Disease
Background Weight gain and metabolic disorders are commonly induced by antipsychotics. Orlistat is a lipase inhibitor used for weight control. The effect of orlistat on weight gain and metabolic disturbances in people (especially women) treated with ...
Peng Xie, Tiannan Shao, Yujun Long, Weiwei Xie, Yangjun Liu, Ye Yang, Yuyan Huang, Renrong Wu, Qijian Deng, Hui Tang   +9 more
doaj   +1 more source

ANALISIS EFEKTIVITAS ORLISTAT TERHADAP PENURUNAN BERAT BADAN PADA PENDERITA OBESITAS [PDF]

, 2021
Backoground : Obesity is accumulation of excess fat due to an imbalance of energy intake with the energy use for a long time. Indonesia is a country with a relatively high number of obese sufferers, both in adults, adolescents and children.
Rosyidah, Devi Usdiana, Nugroho, Hafid Adi   +1 more
core  

Orlistat targets NEDD8 conjugating enzyme UBC12 for cancer therapy

Pharmacological Research
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide, and one of the best-characterized drivers is oncogenic Wnt signaling.
Mengzhen Shen, Huihui Li, Ying Xuan, Hongyan Zhu, Lizhe Chen, Piliang Hao, Chengqian Zhang, Jiansong Fang, Xianglian Zhou, Rong Yan, Yi Qu, Xisong Ke   +11 more
doaj   +1 more source

Eating behaviour during a weight loss therapy with orlistat or placebo [PDF]

, 2005
Im Rahmen der 18monatigen Studie (multizentrisch, placebokontrolliert) zur Wirksamkeit von Orlistat wurde das Ernährungsverhalten analysiert. Gewichtsverluste unter Orlistat waren größer im Vergleich zu Placebo. Die durchschnittliche Energiezufuhr war in
Höhne, Kristina
core  

Chemical modification and organelle-specific localization of orlistat-like natural-product-based probes

, 2011
Orlistat, also known as tetrahydrolipstatin (THL), is an FDA-approved anti-obesity drug with potential anti-cancer activity. Previously, we developed a chemical proteomic approach, based on the Orlistat-like probe (1a) for large-scale identification of ...
Chongjing Zhang (4176322), Mun Hong Ngai (2324311), Grace Y. J. Chen (17192404), Martin Lear (17161933), Yuan Shen (194742), Kai Liu (159026), Peng-Yu Yang (1319298), Shao Q. Yao (1525546)   +7 more
core   +2 more sources

Dynamics of lipid profile and circadian pressure rhythms in patients with obesity and arterial hypertension, treated with orlistat and its combination with ACE inhibitors

Кардиоваскулярная терапия и профилактика, 2005
Aim. To assess effects of orlistat and its combimation with enalapril on main cardiovascular risk parameters in young patients with obesity and arterial hypertension. Material and methods.
A. G. Avtandilov, A. S. Ametov, A. K. Ausheva, A. K. Bolotseva   +3 more
doaj  

Impact of Orlistat-Induced Weight Loss on Diastolic Function and Heart Rate Variability in Severely Obese Subjects with Diabetes

Journal of Obesity, 2011
Objective. Determine the impact of Orlistat-induced weight loss on metabolic profile and cardiovascular function in severely obese patients with type 2 diabetes. Methods.
Julie Martin, Carmen Paquette, Simon Marceau, Frédéric-Simon Hould, Stéfane Lebel, Serge Simard, Jean-Gaston Dumesnil, Paul Poirier   +7 more
doaj   +1 more source